A Guide to Drug Use During Percutaneous Coronary Intervention

Author： Choo J.K. Young J.J. Kereiakes D.J.

ISSN： 0012-6667

Source： Drugs, Vol.62, Iss.18, 2002-01, pp. : 2589-2601

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prasugrel: A Guide to Its Use in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in the US

By Lyseng-Williamson Katherine A.

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 3, 2012-06 ,pp. : 207-216

Adis International

Access to resources Recommend Favorite

Use of Antiplatelet Therapy after Percutaneous Coronary Intervention with Bare-Metal Stents and Different Types of Drug-Eluting Stents

Current Clinical Pharmacology, Vol. 8, Iss. 1, 2013-02 ,pp. : 59-66

Bentham Science Publishers

Access to resources Recommend Favorite

Drug-Eluting Stents in Percutaneous Coronary Intervention: A Benefit-Risk Assessment

By Byrne Robert A. Sarafoff Nikolaus Kastrati Adnan Schömig Albert

Drug Safety, Vol. 32, Iss. 9, 2009-09 ,pp. : 749-770

Adis International

Access to resources Recommend Favorite

Use of Prolonged Bivalirudin Infusions Following Percutaneous Coronary Intervention

By Moser Lynette

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 3, 2011-06 ,pp. : 267-276

Springer Publishing Company

Access to resources Recommend Favorite

Bivalirudin: A Review of its Use in Patients Undergoing Percutaneous Coronary Intervention

By Moen Marit D. Keating Gillian M. Wellington Keri

Drugs, Vol. 65, Iss. 13, 2005-01 ,pp. : 1869-1891

Adis International

Access to resources Recommend Favorite